Efficacy and Tolerability of Newer Antihistamines in the Treatment of Allergic Conjunctivitis

@article{Bielory2012EfficacyAT,
  title={Efficacy and Tolerability of Newer Antihistamines in the Treatment of Allergic Conjunctivitis},
  author={Leonard Bielory and Kenneth W. Lien and Stephen Bigelsen},
  journal={Drugs},
  year={2012},
  volume={65},
  pages={215-228}
}
Treatment for allergic conjunctivitis has markedly expanded in recent years, providing opportunities for more focused therapy, but often leaving both physicians and patients confused over the variety of options. As monotherapy, oral antihistamines are an excellent choice when attempting to control multiple earlyphase, and some late-phase, allergic symptoms in the eyes, nose and pharynx. Unfortunately, despite their efficacy in relief of allergic symptoms, systemic antihistamines may result in… Expand

Paper Mentions

Interventional Clinical Trial
This study compares the efficacy of Hylo-Dual (Hyaluronic acid 0.05% & Ectoine 2.0%) and Olopatadine (Olopatadine hydrochloride ophthalmic solution 0.1%) in the control of seasonal… Expand
ConditionsConjunctivitis, Allergic, Conjunctivitis, Vernal
InterventionDrug
Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis
TLDR
Because it can often produce maximal effect with just twice-daily dosing, azelastine is a particularly good choice for the allergic population in whom minimizing exposure to topical products and preservatives is a key concern. Expand
Topical Corticosteroids and Antihistamines—Mast Cell Stabilizers for the Treatment of Allergic Conjunctivitis
TLDR
The most common ocular manifestation of allergy, allergic conjunctivitis (ac), is the result of a hypersensitivity response occurring after exposure of the ocular surface to airborne antigens and corticosteroids offer the most complete option for ac, although their use has been limited due to concerns about increased intraocular pressure and the potential for cataract formation with extended use. Expand
Phase II drugs under investigation for allergic conjunctivitis
TLDR
The most interesting agents, under development, are the new topical glucocorticoids, leukotriene receptor antagonists, resolvins, interleukin-1 receptor antagonists and integrin antagonists. Expand
ICON: Diagnosis and Management of Allergic Conjunctivitis.
TLDR
Successful management includes overcoming the challenges of under diagnosis and even misdiagnosis by a better understanding of the subtleties of an in-depth patient history, ophthalmologic examination techniques, and diagnostic procedures which are of paramount importance in making an accurate diagnosis of OA. Expand
The anti-inflammatory effects of therapies for ocular allergy.
  • F. Mantelli, V. Calder, S. Bonini
  • Medicine
  • Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
  • 2013
TLDR
A review of topical therapies utilized to treat the various forms of allergic conjunctivitis, starting from the first drugs developed in the 1980s up to the new compounds that are currently being developed, with a special focus on specific signs and symptoms related to them. Expand
Bepotastine besilate for the treatment of pruritus
TLDR
Bepotastine besilate 1.5% ophthalmic solution is a safe and effective treatment option for allergic conjunctivitis associated pruritus and side-effect profile is similar to other ocular antihistamine agents. Expand
Should Intranasal Corticosteroids Be Used for the Treatment of Ocular Symptoms of Allergic Rhinoconjunctivitis? A Review of Their Efficacy and Safety Profile
TLDR
Intranasal corticosteroids are the most effective treatment for the nasal symptoms of seasonal allergic rhinitis (SAR) and are considered first-line therapy when nasal congestion forms a substantial component of the patient’srhinitis symptoms. Expand
Antihistamines and itch.
TLDR
It has now been shown that a selective H₄R antagonist can inhibit histamine-induced itch in humans, which points to the therapeutic potential of H‽R antagonists for the treatment of pruritus not controlled by antihistamines that target the H⁁R. Expand
A review of non-pharmacological and pharmacological management of seasonal and perennial allergic conjunctivitis.
TLDR
Based on current evidence, the efficacy of anti-allergic medications appears equivocal so prescribing should relate to patient preference, dosing and cost, and more studies with standardised methodologies are necessary elicit the most effective anti- allergic medications. Expand
A prospective study of efficacy and safety of olopatadine versus azelastine in allergic conjunctivitis at a tertiary care hospital
TLDR
In allergic conjunctivitis, both olopatadine and azelastine were found to be effective in relieving ocular signs and symptoms, but olop atadine was found to been superior in terms of efficacy, safety and tolerability with minimal side effects. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 146 REFERENCES
The added benefit of local Patanol therapy when combined with systemic Claritin for the inhibition of ocular itching in the conjunctival antigen challenge model.
TLDR
Pat eyes treated with Patanol were significantly less itchy than those treated with systemic Claritin alone at critical time points 3, 7, and 10 minutes after the onset of action challenge (p < 0.05). Expand
Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge.
TLDR
Concomitant use of the topical agents fluticasone and olopatadine was more effective than concomitantuse of flutic asone plus fexofenadine for overall treatment of the signs and symptoms of induced allergic rhinoconjunctivitis. Expand
Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis.
TLDR
Desloratadine rapidly and safely reduced the symptoms of perennial allergic rhinitis, and its efficacy did not diminish during 4 weeks of treatment. Expand
Efficacy of an oral antihistamine, loratadine, as compared with a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis.
  • L. Frølund
  • Medicine
  • Clinical otolaryngology and allied sciences
  • 1991
TLDR
It is concluded that loratadine and intranasal BDP were effective in the treatment of seasonal allergic rhinitis, but the spectrum of individual symptoms controlled was different for the 2 drugs. Expand
Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.
TLDR
Keatifen ophthalmic solution significantly decreased the signs and symptoms of ocular and nasal allergic rhinoconjunctivitis and the addition of ketotifen to the oral desloratadine regimen improved the overall antiallergic efficacy of both medications. Expand
The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis.
TLDR
Combination therapy is more effective than fexofenadine alone or pseudoephedrine alone in relieving the full spectrum of SAR symptoms (ie, both the primarily histamine-related symptoms and nasal congestion). Expand
Topical azelastine in perennial allergic conjunctivitis
TLDR
Topical azelastine progressively improved itching and conjunctival redness in PAC patients compared to placebo and was at least as effective as levocabastine. Expand
Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis.
TLDR
In this CAC model, multiple signs and symptoms of allergic conjunctivitis were significantly reduced by instillation of epinastine compared with vehicle and the tolerability of epInastine was similar to that of vehicle. Expand
Cetirizine : A Reappraisal of its Pharmacological Properties and Therapeutic Use in Selected Allergic Disorders.
TLDR
Cetirizine 10 mg/day appears to be as effective as conventional dosages of other established antihistamines such as astemizole, hydroxyZine, ketotifen, loratadine or terfenadine in relieving symptoms of these disorders, and is associated with a significantly lower incidence of sedation than hydroxyzine. Expand
Comparison of the efficacy and tolerability of topically administered azelastine, sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis and rhino-conjunctivitis
TLDR
The results of this study indicate that the therapeutic use of azelastine eye drops in patients with seasonal allergic conjunctivitis or rhino-conjunctivoitis can be recommended. Expand
...
1
2
3
4
5
...